# Clinical review checklist

All patients, investigations and screening figures in these demonstrations are **synthetic**. Content requires educator review before student use.

## Review status

| Item | Status |
| --- | --- |
| Case A — A worrying test result | Draft for staff demonstration |
| Case B — Breathlessness on the assessment unit | `draft_for_staff_demonstration` |
| Open Practice prompts and activity preparation | Draft — formative only |
| NICE NG158 / NHS PE references | Teaching references only — not NHS Lothian policy |

## Case A facts and teaching statements to sign off

- [ ] Opening vignette wording (fictional Condition X, 90% sensitivity, 95% specificity, 1% prevalence)
- [ ] Reference calculation PPV ≈ 15.4% (2/13) using natural frequencies
- [ ] Criteria A1–A4 and misconception descriptions
- [ ] Hint ladder (nudge → framework → cue → explanation)
- [ ] Expert explanation used in completed feedback
- [ ] Safety wording: not a real screening recommendation; no invented confirmatory pathway

## Case B facts and teaching statements to sign off

### Stage 1
- [ ] Public facts B1F1–B1F6 and opening question
- [ ] Criteria B1C1–B1C3 (stability/supervision, differential, linking features)
- [ ] Hints and reference note

### Stage 2
- [ ] Released facts (surgery, calf findings, examination negatives)
- [ ] Criteria B2C1–B2C3 and thromboembolism teaching emphasis

### Stage 3
- [ ] Wells category supplied as PE likely; CTPA available promptly
- [ ] Criteria B3C1–B3C3 and compact NICE NG158 teaching boundary
- [ ] Explicit non-claim that this is local protocol

### Stage 4
- [ ] CTPA result wording and stable observations
- [ ] Criteria separating diagnosis from severity/disposition

### Stage 5
- [ ] Anticoagulation purpose explanation (prevent extension; not instant dissolution)
- [ ] No invented dose/duration/disposition
- [ ] Full expert synthesis for completed attempts only

### Safety corrections
- [ ] Policy for dismissing presentation without assessment
- [ ] Cap-with-explanation behaviour before progression
- [ ] Early-finish feedback must not reveal unreleased scan results

## Sign-off

| Role | Name | Date | Decision |
| --- | --- | --- | --- |
| Clinical educator | | | Pending |
| Educational lead | | | Pending |

Do not label this content clinically approved until the table above is completed.